ArticleLaryngoscope investigative otolaryngology2025

FDA-Approved Biologics for CRSwNP: A Five-Year Analysis of the FDA Adverse Event Reporting System.

Radhika Duggal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.